GXO vs DOCS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 25, 2026

GXO

54.2
AI Score
VS
DOCS Wins

DOCS

58.6
AI Score

Investment Advisor Scores

GXO

54score
Recommendation
HOLD

DOCS

59score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric GXO DOCS Winner
Revenue 3.30B 499.49M GXO
Net Income 4.00M 176.94M DOCS
Net Margin 0.1% 35.4% DOCS
Operating Income 39.00M 190.09M DOCS
ROE 0.1% 18.1% DOCS
ROA 0.0% 15.3% DOCS
Total Assets 12.19B 1.16B GXO
Cash 794.00M 64.84M GXO
Current Ratio 0.85 6.63 DOCS

Relative Price Performance (Last 90 Days)

GXO 1M: -2.6% · 3M: -10.0% DOCS 1M: -0.9% · 3M: -13.3%

Current Technical Phase

GXO

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope 0.2%) with fading momentum, RSI 46

RSI (14): 45.8 · Price: $50.62

DOCS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 52.9 · Price: $21.66

Fundamentals Snapshot

Metric GXO DOCS
Market Cap
Forward P/E 14.3 13.4
Trailing P/E 44.8 21.3
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.2% 0.9%
Operating Margin 0.0% 0.2%
EPS 1.12 0.98
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, DOCS is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.